Product Information
IPRATROPIUM BR 0.02% SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1122 per ML under NDC 00378797093. Its NADAC has been published 375 times since Jul 31, 2019.
FDA first approved this application on Jan 26, 2001. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2.5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378797093
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075693FDA Approved
1/26/2001
TE Code
AN
On Market Since
11/9/2010
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM BR 0.02% SOLN has been published 375 times since Jul 31, 2019, and over the history we have for it it has risen 119.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1122 per ML |
|---|---|
| All-time high | $0.1156 (Aug 12, 2026) |
| All-time low | $0.0512 (Jul 31, 2019) |
| 52-week high | $0.1156 |
| 52-week low | $0.0997 |
| Median price | $0.0633 |
| Average price | $0.0765 |
| Largest weekly change | +18.1% (Mar 20, 2024) |
| Weeks tracked | 375 |
| Tracking since | Jul 31, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM BR 0.02% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM BR 0.02% SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.1122 per ML (NDC 00378797093), effective Sep 30, 2026.
How has the price of IPRATROPIUM BR 0.02% SOLN changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM BR 0.02% SOLN has risen 119.3%. It has been tracked across 375 weekly CMS publications since Jul 31, 2019.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM BR 0.02% SOLN?
Since Jul 31, 2019, the NADAC for IPRATROPIUM BR 0.02% SOLN has ranged from a low of $0.0512 (Jul 31, 2019) to a high of $0.1156 (Aug 12, 2026), with a median of $0.0633 per ML.
Are there cheaper alternatives to IPRATROPIUM BR 0.02% SOLN?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IPRATROPIUM BR 0.02% SOLN, is $0.0529 per ML — about 53% below IPRATROPIUM BR 0.02% SOLN.
Who manufactures IPRATROPIUM BR 0.02% SOLN?
IPRATROPIUM BR 0.02% SOLN (NDC 00378797093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.